Repeat STI Screening May Cut Preterm Birth Risk
In a South African trial, pregnant women screened twice for STIs had a 23% lower risk of preterm birth.
Updated on Nov. 4, 2026 in Pregnancy

Live Poll
Would you ask your doctor for STI screening during a future pregnancy even without symptoms?
A clinical trial in South Africa found that screening pregnant women twice for sexually transmitted infections (chlamydia, gonorrhea, and trichomoniasis) was associated with a 23% reduction in preterm birth risk. The trial, which recruited more than 2,200 women at four government health clinics, is relevant to prenatal care providers and pregnant people worldwide.
Why it matters
Preterm birth is a leading driver of complications for newborns, and the trial suggests that a routine, low-cost screening step during pregnancy may help reduce it. Because about 80% of women who tested positive had no symptoms, the findings point to the value of testing that does not depend on noticing signs of infection.
This randomized trial assigned pregnant women at four South African government clinics to single screening, double screening, or standard symptom-based care. The 23% reduction in preterm birth was seen in the double-screening group compared with the standard-care comparison, though the trial did not settle how often screening should occur.
The players
University of Pennsylvania
A private research university in Philadelphia whose researchers conduct extensive work in maternal and reproductive health, and whose institution issued the news release on this trial.
The details
Women in the screening groups were tested for STIs at their first prenatal visit, and those who tested positive received treatment and follow-up testing. Women in the double-screening group were tested a second time between 30 and 34 weeks of pregnancy, which is when the study found the benefit most clearly appeared. The researchers' results suggest that rescreening captures infections that develop or are missed early in pregnancy.
Timeline
Oct. 29, 2026: University of Pennsylvania published a news release on the trial.
30 to 34 weeks of pregnancy: Second screening window for the double-screening group.
Nov. 4, 2026: HealthDay reported the trial findings.
Health Landscape
Routine screening for STIs during pregnancy is already a part of many national prenatal programs, but how often screening should occur has been less clearly established. This trial adds evidence on the value of repeat testing in the later part of pregnancy, a question that shapes both clinical practice and public health budgeting for prenatal care.
Pregnant people may want to ask their prenatal care provider whether repeat STI testing later in pregnancy is part of their care, since many infections do not cause noticeable symptoms. This finding is worth discussing with your doctor or midwife, who can advise on testing that fits your situation.
The takeaway
Repeated STI screening during pregnancy may help lower the risk of preterm birth, particularly because most infections found in the study had no symptoms. Ask your prenatal care provider how and when STI testing is handled in your pregnancy care.
Further reading
For more background on prenatal care and pregnancy health, explore our Pregnancy coverage.
Live Poll
Would you ask your doctor for STI screening during a future pregnancy even without symptoms?


